Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2023-2029

Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2023-2029

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

LPI (LP Information)' newest research report, the “Mesenchymal Stem Cells Industry Forecast” looks at past sales and reviews total world Mesenchymal Stem Cells sales in 2022, providing a comprehensive analysis by region and market sector of projected Mesenchymal Stem Cells sales for 2023 through 2029. With Mesenchymal Stem Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesenchymal Stem Cells industry.

This Insight Report provides a comprehensive analysis of the global Mesenchymal Stem Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesenchymal Stem Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesenchymal Stem Cells market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesenchymal Stem Cells and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesenchymal Stem Cells.

The global Mesenchymal Stem Cells market size is projected to grow from US$ 202.6 million in 2022 to US$ 278.8 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.

The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.

North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.

This report presents a comprehensive overview, market shares, and growth opportunities of Mesenchymal Stem Cells market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Human MSC

Mouse MSC

Rat MSC

Others

Segmentation by application

Research Institute

Hospital

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Lonza

Thermo Fisher

Bio-Techne

ATCC

MilliporeSigma

PromoCell GmbH

Genlantis

Celprogen

Cell Applications

Cyagen Biosciences

Axol Bioscience

Please note: The report will take approximately 2 business days to prepare and deliver.